98%
921
2 minutes
20
When Escherichia coli grows in the presence of DNA-damaging agents such as methyl methanesulphonate (MMS), absence of the full-length form of Translation Initiation Factor 2 (IF2-1) or deficiency in helicase activity of replication restart protein PriA leads to a considerable loss of viability. MMS sensitivity of these mutants was contingent on the stringent response alarmone (p)ppGpp being at low levels. While zero levels (ppGpp°) greatly aggravated sensitivity, high levels promoted resistance. Moreover, M+ mutations, which suppress amino acid auxotrophy of ppGpp° strains and which have been found to map to RNA polymerase subunits, largely restored resistance to IF2-1- and PriA helicase-deficient mutants. The truncated forms IF2-2/3 played a key part in inducing especially severe negative effects in ppGpp° cells when restart function priB was knocked out, causing loss of viability and severe cell filamentation, indicative of SOS induction. Even a strain with the wild-type infB allele exhibited significant filamentation and MMS sensitivity in this background whereas mutations that prevent expression of IF2-2/3 essentially eliminated filamentation and largely restored MMS resistance. The results suggest different influences of IF2-1 and IF2-2/3 on the replication restart system depending on (p)ppGpp levels, each having the capacity to maximize survival under differing growth conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008491 | PMC |
http://dx.doi.org/10.1111/mmi.12538 | DOI Listing |
Ann Hematol
September 2025
Excellence Center for Comprehensive Cancer (ECCCC), King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Despite therapeutic advances, multiple myeloma (MM) remains incurable, especially in relapsed/refractory (R/R) cases. B-cell maturation antigen (BCMA) is a key target for novel immunotherapies, including chimeric antigen receptor T-cell (CAR-T) therapies and bispecific T-cell engagers (BiTEs), which vary in efficacy, toxicity, and accessibility. To compare the efficacy and safety of BCMA-directed CAR-T therapies and BiTEs in R/R MM through a systematic review and meta-analysis.
View Article and Find Full Text PDFACS Nano
September 2025
School of Microelectronics, University of Science and Technology of China, Hefei, Anhui 230026, China.
Superlinear photodetectors hold significant potential in intelligent optical detection systems, such as near-field imaging. However, their current realization imposes stringent requirements on photosensitive materials, thereby limiting the flexibility of the device integration for practical applications. Herein, a tunable superlinear GaO deep-ultraviolet gate-all-around (GAA) phototransistor based on a p-n heterojunction has been proposed.
View Article and Find Full Text PDFPestic Biochem Physiol
November 2025
Department of GreenBio Science, Gyeongsang National University, Jinju 52725, Republic of Korea. Electronic address:
Bromuconazole, a widely used triazole-based pesticide, effectively controls fungal diseases in agriculture. Bromuconazole cause a potential toxic effect to non-target organisms and can have a negative impact on reproductive health in women, due to its long half-life and bioaccumulation ability. This study identifies the cytotoxicity and adverse effects of bromuconazole on trophoblastic cells (HTR-8/SVneo) and human endometrial cells (T HESCs), which are involved in implantation processes.
View Article and Find Full Text PDFJ Endocrinol Invest
September 2025
Department of Medicine-DIMED, University of Padova, Padova, Italy.
Background: Cushing's syndrome (CS) is associated with increased metabolic and cardiovascular (CV) risk factors and morbidities. Evidence-based guidelines for the management of these issues in active or remitted CS are not available, so best practice is derived from guidelines developed for the general population. We aimed to evaluate the awareness and practice variation for CV comorbidities of CS across Reference Centres (RCs) of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
View Article and Find Full Text PDFStat Methods Med Res
September 2025
Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The integration of backfill cohorts into Phase I clinical trials has garnered increasing interest within the clinical community, particularly following the "Project Optimus" initiative by the U.S. Food and Drug Administration, as detailed in their final guidance of August 2024.
View Article and Find Full Text PDF